Curia Sterile Drug Product

Home | Curia Sterile Drug Product | Commercial Manufacturing

Commercial Manufacturing

Commercial manufacturing in the U.S. for biologics and small molecules (viscous biopolymers, suspensions, liposomes & nanoparticles, proteins, peptides, monoclonal antibodies, and emulsions), including highly potent products.

Your partner on the journey From Curiosity to Cure®

Commercial Sterile Drug Product Locations

Bulk Capacity
1-1200 L

GMP Dose Filling Lines
Vials, syringes & cartridges

Validated For
2 – 100 mL vials 1 – 10 mL syringes

Non-cyto
Liquid and lyophilized

Cyto/Highly Potent
Liquid and lyophilized

Expertise and Capabilities

  • Microfluidization/high-shear homogenization/extrusion
  • Suspensions/emulsions/liposomal/nanoparticles
  • Small molecule
  • Proteins/peptides/oligonucleotides
  • Monoclonal antibodies (mAbs)
  • Inactivated and attenuated live virus
  • Late phase clinical and commercial
  • Full in-house QC /Microbiology services (including sterility testing)
  • Stability Services

Quality and Regulatory

  • FDA and EU Approved
  • DEA registration for Schedule II-V controlled substances

The power of a partnership with Curia

Deep expertise

cGMP manufacturing for 50+ commercialized products

Controlled substance capabilities

DEA registration (Schedule II-V)

Various formats

Vials, syringes and cartridges

Continuous improvement

$200 million investment expanding Albuquerque, NM facility

Drug Product Insights

View All Insights

Curia Sterile Drug Product: Fact Sheet

Read More

In Pursuit of High Concentration Protein Formulation

Read More

Prefilled Syringes & Biologics: The Perfect Partnership of Medicine & Delivery

Read More